179 related articles for article (PubMed ID: 36000298)
1. Molecular and immune targets in cutaneous squamous cell carcinoma.
Galambus J; Tsai KY
Mol Carcinog; 2023 Jan; 62(1):38-51. PubMed ID: 36000298
[TBL] [Abstract][Full Text] [Related]
2. Systemic Therapies for Advanced Basal Cell and Cutaneous Squamous Cell Carcinomas: Novel Targeted Therapies and Immunotherapies.
Krišto M; Šitum M; Čeović R
Acta Dermatovenerol Croat; 2020 Aug; 28(2):80-92. PubMed ID: 32876033
[TBL] [Abstract][Full Text] [Related]
3. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.
Ogata D; Tsuchida T
Curr Treat Options Oncol; 2019 Mar; 20(4):30. PubMed ID: 30874952
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma.
Bottomley MJ; Thomson J; Harwood C; Leigh I
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022866
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
7. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
Bonini F; de Sousa LG; Ferrarotto R
Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
[TBL] [Abstract][Full Text] [Related]
8. Molecular prediction of metastasis in cutaneous squamous cell carcinoma.
Mulvaney PM; Schmults CD
Curr Opin Oncol; 2020 Mar; 32(2):129-136. PubMed ID: 31850970
[TBL] [Abstract][Full Text] [Related]
9. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinoma: state of the art, perspectives and unmet needs.
Heppt MV; Leiter U
J Dtsch Dermatol Ges; 2023 Apr; 21(4):421-424. PubMed ID: 36999577
[TBL] [Abstract][Full Text] [Related]
11. Challenges and new perspectives in the treatment of advanced cutaneous squamous cell carcinoma.
Brancaccio G; Moscarella E; Briatico G; Verolino P; Alfano R; Argenziano G
Minerva Med; 2020 Dec; 111(6):589-600. PubMed ID: 32955822
[TBL] [Abstract][Full Text] [Related]
12. Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy.
Palazzo E; Morasso MI; Pincelli C
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059344
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review.
Newman JG; Hall MA; Kurley SJ; Cook RW; Farberg AS; Geiger JL; Koyfman SA
Head Neck; 2021 Sep; 43(9):2822-2843. PubMed ID: 34096664
[TBL] [Abstract][Full Text] [Related]
14. Targeted Therapy and Traditional Chemotherapy in Melanoma and Cutaneous Squamous Cell Carcinoma.
Ma VT; Haring CT; Warrier G; Swiecicki PL
Facial Plast Surg; 2020 Apr; 36(2):186-193. PubMed ID: 32413927
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
17. Advances in cutaneous squamous cell carcinoma.
Winge MCG; Kellman LN; Guo K; Tang JY; Swetter SM; Aasi SZ; Sarin KY; Chang ALS; Khavari PA
Nat Rev Cancer; 2023 Jul; 23(7):430-449. PubMed ID: 37286893
[TBL] [Abstract][Full Text] [Related]
18. Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.
Khaddour K; Musiek A; Cornelius LA; Dehdashti F; Westervelt P; Fields R; Ansstas G
J Immunother Cancer; 2019 Dec; 7(1):338. PubMed ID: 31801591
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?
Ribero S; Stucci LS; Daniels GA; Borradori L
Curr Opin Oncol; 2017 Mar; 29(2):129-135. PubMed ID: 28151757
[TBL] [Abstract][Full Text] [Related]
20. Treatment approaches in immunosuppressed patients with advanced cutaneous squamous cell carcinoma.
Willenbrink TJ; Jambusaria-Pahlajani A; Arron S; Seckin D; Harwood CA; Proby CM
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():57-60. PubMed ID: 31833603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
